Eagle Bay Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-458
| Closed | -$150K | – | 956 |
|
|
2024
Q4 | $150K | Sell |
458
-13
| -3% | -$4.26K | 0.09% | 141 |
|
|
2024
Q3 | $141K | Sell |
471
-29
| -6% | -$8.71K | 0.05% | 222 |
|
|
2024
Q2 | $165K | Sell |
500
-77
| -13% | -$25.4K | 0.1% | 138 |
|
|
2024
Q1 | $228K | Sell |
577
-270
| -32% | -$107K | 0.14% | 117 |
|
|
2023
Q4 | $298K | Sell |
847
-239
| -22% | -$84.2K | 0.19% | 90 |
|
|
2023
Q3 | $407K | Buy |
1,086
+197
| +22% | +$73.9K | 0.19% | 79 |
|
|
2023
Q2 | $340K | Sell |
889
-49
| -5% | -$18.7K | 0.19% | 77 |
|
|
2023
Q1 | $325K | Sell |
938
-104
| -10% | -$36K | 0.18% | 85 |
|
|
2022
Q4 | $245K | Buy |
1,042
+490
| +89% | +$115K | 0.14% | 111 |
|
|
2022
Q3 | $136K | Sell |
552
-300
| -35% | -$73.9K | 0.08% | 155 |
|
|
2022
Q2 | $258K | Buy |
852
+310
| +57% | +$93.7K | 0.16% | 103 |
|
|
2022
Q1 | $222K | Sell |
542
-80
| -13% | -$32.8K | 0.18% | 87 |
|
|
2021
Q4 | $292K | Buy |
622
+58
| +10% | +$27.2K | 0.19% | 75 |
|
|
2021
Q3 | $239K | Buy |
564
+161
| +40% | +$68.2K | 0.13% | 110 |
|
|
2021
Q2 | $145K | Buy |
+403
| New | +$145K | 0.12% | 114 |
|